Chemoinformaics analysis of Tetraacetylbrazilin
| Molecular Weight | 454.431 | nRot | 4 |
| Heavy Atom Molecular Weight | 432.255 | nRig | 24 |
| Exact Molecular Weight | 454.126 | nRing | 4 |
| Solubility: LogS | -6.015 | nHRing | 1 |
| Solubility: LogP | 2.621 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 12 |
| nHA | 9 | APOL | 61.9674 |
| nHD | 0 | BPOL | 34.2226 |
| QED | 0.508 |
| Synth | 3.788 |
| Natural Product Likeliness | 1.302 |
| NR-PPAR-gamma | 0.469 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.722 |
| Pgp-sub | 0.207 |
| HIA | 0.489 |
| CACO-2 | -5.163 |
| MDCK | 0.0000256 |
| BBB | 0.184 |
| PPB | 0.719038 |
| VDSS | 0.457 |
| FU | 0.404008 |
| CYP1A2-inh | 0.194 |
| CYP1A2-sub | 0.041 |
| CYP2c19-inh | 0.517 |
| CYP2c19-sub | 0.194 |
| CYP2c9-inh | 0.741 |
| CYP2c9-sub | 0.857 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.214 |
| CYP3a4-inh | 0.507 |
| CYP3a4-sub | 0.595 |
| CL | 1.142 |
| T12 | 0.415 |
| hERG | 0.001 |
| Ames | 0.029 |
| ROA | 0.414 |
| SkinSen | 0.117 |
| Carcinogencity | 0.056 |
| EI | 0.022 |
| Respiratory | 0.292 |
| NR-Aromatase | 0.433 |
| Antiviral | Yes |
| Prediction | 0.895628 |